Vanguard Group’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$82M Buy
9,691,445
+295,701
+3% +$2.11M ﹤0.01% 1947
2025
Q3
$49M Buy
9,395,744
+15,893
+0.2% +$60.6K ﹤0.01% 2163
2025
Q2
$32.5M Sell
9,379,851
-2,725,569
-23% -$8.11M ﹤0.01% 2325
2025
Q1
$31.7M Sell
12,105,420
-2,924,789
-19% -$11.5M ﹤0.01% 2289
2024
Q4
$61.9M Buy
15,030,209
+566,595
+4% +$3.08M ﹤0.01% 2075
2024
Q3
$102M Buy
14,463,614
+2,758,748
+24% +$20.6M ﹤0.01% 1860
2024
Q2
$76.3M Sell
11,704,866
-110,803
-0.9% -$757K ﹤0.01% 1964
2024
Q1
$98.1M Buy
11,815,669
+1,165,282
+11% +$11.4M ﹤0.01% 1878
2023
Q4
$117M Buy
10,650,387
+98,025
+0.9% +$827K ﹤0.01% 1781
2023
Q3
$88.7M Buy
10,552,362
+23,795
+0.2% +$256K ﹤0.01% 1872
2023
Q2
$132M Buy
10,528,567
+29,053
+0.3% +$361K ﹤0.01% 1694
2023
Q1
$173M Buy
10,499,514
+115,296
+1% +$2.07M ﹤0.01% 1527
2022
Q4
$155M Buy
10,384,218
+2,024,698
+24% +$38.8M ﹤0.01% 1575
2022
Q3
$187M Buy
8,359,520
+1,261,066
+18% +$27.7M 0.01% 1424
2022
Q2
$119M Buy
7,098,454
+880,831
+14% +$18.9M ﹤0.01% 1714
2022
Q1
$186M Buy
6,217,623
+19,181
+0.3% +$465K ﹤0.01% 1601
2021
Q4
$190M Buy
6,198,442
+1,314,405
+27% +$41.5M ﹤0.01% 1642
2021
Q3
$154M Buy
4,884,037
+590,595
+14% +$19.9M ﹤0.01% 1749
2021
Q2
$157M Buy
4,293,442
+242,361
+6% +$7.99M ﹤0.01% 1758
2021
Q1
$140M Buy
4,051,081
+2,330,406
+135% +$101M ﹤0.01% 1772
2020
Q4
$71.5M Buy
1,720,675
+88,701
+5% +$4.01M ﹤0.01% 2016
2020
Q3
$69.5M Buy
+1,631,974
New +$62.2M ﹤0.01% 1852

Other funds holding RLAY